About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Food and Crohn's Exacerbation Study (FACES)

NCT01926730·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Pennsylvania

With

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Crohn's and Colitis Foundation

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Patients must have an established diagnosis of CD.
2. All patients must be in clinical remission at the time of entry into the study. Remission is defined as an aCDAI of less than 150.

You may not be if

Inflammatory bowel disease (IBD) unspecified / Indeterminate colitis
Total or sub-total colectomy, ileostomy, or colostomy
Unable to read and speak English
No internet access
Steroids other than budesonide ≤6mg/day with the prior two weeks
Perianal fistula or abscess with more than scant drainage
Age less than 18 years
Pregnant or breastfeeding women
Unwilling to follow the study diet

The record

StatusCompleted

PhaseNo phase

Taking part216

StartedNov 2013

UpdatedFeb 14, 2017

Conditions

Crohn's Disease

Where1

University of Pennsylvania
Philadelphia, Pennsylvania, United States

Clareo Health | Food and Crohn's Exacerbation Study (FACES)